Effects of different general anaesthetic techniques on immune responses in patients undergoing surgery for tongue cancer

Anaesthesia and Intensive Care

Volumn 42, Issue 2, 2014, Pages 220-227

  Zhang, Tiejun ^a   Fan, Y ^a,b   Liu, K ^a   Wang, Y ^a  

^a WUHAN UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Anaesthesia; General; Immunity; Tongue neoplasms

Indexed keywords

PROPOFOL; REMIFENTANIL; SEVOFLURANE; ETHER DERIVATIVE;

ADULT; ANESTHESIA INDUCTION; ARTICLE; B LYMPHOCYTE; CANCER PATIENT; CANCER SURGERY; CD3+ T LYMPHOCYTE; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG SUBSTITUTION; ELECTIVE SURGERY; FEMALE; FLOW CYTOMETRY; GENERAL ANESTHESIA; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; OPERATION DURATION; PLASTIC SURGERY; RANDOMIZED CONTROLLED TRIAL; T LYMPHOCYTE SUBPOPULATION; TONGUE CANCER; AGED; ANESTHESIA; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; GENERAL; IMMUNITY; IMMUNOLOGY; METHODOLOGY; MIDDLE AGED; TONGUE TUMOR; ANESTHESIA LEVEL; BLOOD SAMPLING; CEREBRAL STATE INDEX;

ANAESTHESIA; GENERAL; IMMUNITY; TONGUE NEOPLASMS;

ADULT; AGED; ANESTHESIA, GENERAL; B-LYMPHOCYTES; HUMANS; KILLER CELLS, NATURAL; METHYL ETHERS; MIDDLE AGED; PROPOFOL; T-LYMPHOCYTE SUBSETS; TONGUE NEOPLASMS;

EID: 84899490592     PISSN: 0310057X     EISSN: 14480271     Source Type: Journal    
DOI: 10.1177/0310057x1404200209     Document Type: Article

References (12)

1. Hogan BV, Peter MB, Shenoy HG, Horgan K, Hughes TA. Surgery induced immunosuppression. Surgeon 2011; 9:38-43.
2. Kurosawa S, Kato M. Anesthetics, immune cells, and immune responses. J Anesth 2008; 22:263-277.
3. Melamed R, Bar-Yosef S, Shakhar G, Shakhar K, Ben-Eliyahu S. Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures. Anesth Analg 2003; 97:1331-1339. (Pubitemid 37310130)
4. Valién JL, Hernando AN, Gascón AH, Francés RC, Lobera JC. Cellular immune response to 3 anesthetic techniques for simple abdominal hysterectomy. Rev Esp Anestesiol Reanim 2007; 54:523-528.
5. Xing CY, Wu MY, Fan HP. Effects of different anesthetic and analgesic protocols on cellular immune function and stress hormone level in patients undergoing lobectomy for esophagus cancer. Nan Fang Yi Ke Da Xue Xue Bao 2010; 30:284-287.
6. Chrousos GP. Seminars in medicine of the Beth Israel Hospital, Boston: the hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995; 332:1351-1362.
7. Kennedy BC, Hall GM. Neuroendocrine and inflammatory aspects of surgery: do they affect outcome. Acta Anaesthesiol Belg 1999; 50:205-209.
8. Vallejo R, Hord ED, Barna SA, Santiago-Palma J, Ahmed S. Perioperative immunosuppression in cancer patients. J Environ Pathol Toxicol Oncol 2003; 22:139-146. (Pubitemid 36750166)
9. Goldfarb Y, Sorski L, Benish M, Levi B, Melamed R, Ben-Eliyahu S. Improving postoperative immune status and resistance to cancer metastasis: a combined perioperative approach of immunostimulation and prevention of excessive surgical stress responses. Ann Surg 2011; 253:798-810.
10. Kitamura T, Ohno N, Bougaki M, Ogawa M, Yamada Y. Comparison of the effects of sevoflurane and propofol on changes in leukocyte-count induced by surgical stress. Masui 2008; 57:968-972.
11. Osaki T, Kimura T, Tatemoto Y, Yamamoto T, Yoneda K. Risk factors of metastasis in oral squamous cell carcinomas. Oncology 2000; 58:137-143. (Pubitemid 30113864)
12. Inada T, Kubo K, Shingu K. Promotion of interferon-gamma production by natural killer cells via suppression of murine peritoneal macrophage prostaglandin E2 production using intravenous anesthetic propofol. Int Immunopharmacol 2010; 10:1200-1208.